BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7188113)

  • 21. Pentoxifylline and cerebrovascular diseases.
    Marcel GA; George C
    Eur Neurol; 1983; 22 Suppl 1():89-97. PubMed ID: 6350013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of furosemide and pentoxifylline on blood flow properties in horses.
    Geor RJ; Weiss DJ; Burris SM; Smith CM
    Am J Vet Res; 1992 Nov; 53(11):2043-9. PubMed ID: 1466500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
    Feher G; Koltai K; Kesmarky G; Horvath B; Toth K; Komoly S; Szapary L
    Phytomedicine; 2009 Mar; 16(2-3):111-7. PubMed ID: 19135345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pentoxifylline in the blood rheological and coagulative changes in chronic respiratory failure].
    Micillo E; Dericoloso A; Tranchese D; Bianco A; Sorrentino L; Di Filippo O
    Arch Monaldi Mal Torace; 1990; 45(1):31-8. PubMed ID: 1669259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of pentoxifylline, a hemorheologic agent for the treatment of intermittent claudication.
    Aviado DM; Dettelbach HR
    Angiology; 1984 Jul; 35(7):407-17. PubMed ID: 6380349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of platelet aggregation in vivo. III. Effect of pentoxifylline.
    Gastpar H; Ambrus JL; Ambrus CM; Spavento P; Weber FJ; Thurber LE
    J Med; 1977; 8(3-4):191-7. PubMed ID: 407320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examinations of the relative fluidity in cerebrovascular disease patients.
    Szobor A; Klein M
    Ther Hung; 1992; 40(1):8-11. PubMed ID: 1585286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pentoxifylline administration on blood viscosity and leukocyte cytoskeletal function in patients with intermittent claudication.
    Rao KM; Simel DL; Cohen HJ; Crawford J; Currie MS
    J Lab Clin Med; 1990 Jun; 115(6):738-44. PubMed ID: 2366034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of hemorheologically active treatment with pentoxifylline in patients with cerebrovascular disease.
    Schneider R
    Angiology; 1989 Nov; 40(11):987-93. PubMed ID: 2817522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
    Runge E; Thiele P
    Z Gesamte Inn Med; 1987 Mar; 42(5):137-41. PubMed ID: 3590891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Störmer B; Kleinschmidt F; Loose D; Kremer K
    Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of papaverine and trental on hemostasis and rheologic properties of blood in acute arterial obstruction].
    Zatevakhin II; Koshkin VM; Shestakov VA; Il'in SG; Adil'khanov SG
    Probl Gematol Pereliv Krovi; 1979 Dec; 24(12):40-3. PubMed ID: 523450
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
    Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on vasoocclusive crisis of sickle cell disease. I. Effect of pentoxifylline.
    Ambrus JL; Ambrus CM; Gastpar H; Bannerman R; Bettigole R; Friedman S
    J Med; 1979; 10(6):445-56. PubMed ID: 299453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and blood rheologic effects of ticlid in patients with cerebrovascular diseases].
    Suslina ZA; Ionova VG; Nikitenko NIu; Maksimova MIu
    Ter Arkh; 1993; 65(9):53-6. PubMed ID: 8303598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheological aspects of cerebrovascular disease.
    Ott E; Fazekas F; Tschinkel M; Bertha G; Lechner H
    Eur Neurol; 1983; 22 Suppl 1():35-7. PubMed ID: 6884403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentoxifylline -- a biomedical profile.
    Müller R
    J Med; 1979; 10(5):307-29. PubMed ID: 393789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemorheological background of acetylsalicylic acid resistance.
    Feher G; Koltai K; Kesmarky G; Toth K
    Clin Hemorheol Microcirc; 2008; 38(3):143-52. PubMed ID: 18239256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Parenteral pentoxifylline treatment of ischemic cerebrovascular accident. Preliminary results].
    Schneider R; Kiesewetter H
    Dtsch Med Wochenschr; 1982 Nov; 107(44):1674-7. PubMed ID: 7140544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amelioration of blood viscosity in sickle cell anemia by pentoxifylline. A case report.
    Keller F; Leonhardt H
    J Med; 1979; 10(6):429-33. PubMed ID: 299452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.